Literature DB >> 11668026

Synthesis of hepatic secretory proteins in normal adults consuming a diet marginally adequate in protein.

A A Jackson1, G Phillips, I McClelland, F Jahoor.   

Abstract

The plasma concentration and hepatic synthesis rates of albumin, transthyretin, very low-density lipoprotein apolipoprotein B-100 (VLDL-apoB-100), high-density lipoprotein apolipoprotein A-1, fibrinogen, alpha1-antitrypsin, and haptoglobin were measured in six normal adults before and after consuming a protein intake of 0.6 g. kg body wt(-1). day(-1) for 7 days. The synthesis of hepatic proteins was measured from the incorporation of [(2)H(5)]- phenylalanine, following prime/continuous infusion, using plasma VLDL-apoB-100 isotopic enrichment to represent the precursor pool. Synthesis of albumin declined by 50% (P < 0.001) following the lower-protein diet, VLDL-apoB-100 declined by 20% (P < 0.001), and apoA-1 declined by 16% (P < 0.05). By contrast, synthesis increased for fibrinogen (50%, P < 0.05) and haptoglobin (90%, P < 0.001). This pattern of change, with decreased synthesis of nutrient transport proteins and increased formation of acute-phase proteins, suggestive of a low-grade inflammatory response, was accompanied by increased plasma concentration of the inflammatory cytokine interleukin 6 (30%, P < 0.05). The pattern of change in the synthesis of hepatic secretory proteins following 7 days on the low-protein diet may be of functional relevance for lipid transport and the capacity to cope with stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668026     DOI: 10.1152/ajpgi.2001.281.5.G1179

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  7 in total

1.  Nutritional repletion of children with severe acute malnutrition does not affect VLDL apolipoprotein B-100 synthesis rate.

Authors:  Asha V Badaloo; Terrence Forrester; Marvin Reid; Farook Jahoor
Journal:  J Nutr       Date:  2012-03-21       Impact factor: 4.798

2.  Randomized trial to evaluate nutritional status and absorption of enteral feeding after brain death.

Authors:  Georgene W Hergenroeder; Norman H Ward; Xiaoying Yu; Antone Opekun; Anthony N Moore; Claudia A Kozinetz; David J Powner
Journal:  Prog Transplant       Date:  2013-12       Impact factor: 1.187

3.  Metabolic and genomic response to dietary isocaloric protein restriction in the rat.

Authors:  Satish C Kalhan; Sonal O Uppal; Jillian L Moorman; Carole Bennett; Lourdes L Gruca; Prabhu S Parimi; Srinivasan Dasarathy; David Serre; Richard W Hanson
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

4.  Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation.

Authors:  Jun Zhu; Rong-Jun Gao; Qiang Liu; Ru-Hong Jiang; Lu Yu; Ya-Xun Sun; Pei Zhang; Jian-Wei Lin; Yang Ye; Zu-Wen Zhang; Shi-Quan Chen; Hui Cheng; Xia Sheng; Chen-Yang Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2017 Nov.       Impact factor: 3.066

5.  Nutrient ingestion, protein intake, and sex, but not age, affect the albumin synthesis rate in humans.

Authors:  Anna E Thalacker-Mercer; Craig A Johnson; Kevin E Yarasheski; Nadine S Carnell; Wayne W Campbell
Journal:  J Nutr       Date:  2007-07       Impact factor: 4.798

6.  Intrauterine growth retarded progeny of pregnant sows fed high protein:low carbohydrate diet is related to metabolic energy deficit.

Authors:  Cornelia C Metges; Iris S Lang; Ulf Hennig; Klaus-Peter Brüssow; Ellen Kanitz; Margret Tuchscherer; Falk Schneider; Joachim M Weitzel; Anika Steinhoff-Ooster; Helga Sauerwein; Olaf Bellmann; Gerd Nürnberg; Charlotte Rehfeldt; Winfried Otten
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

7.  Albumin and fibrinogen kinetics in sepsis: a prospective observational study.

Authors:  Keisuke Omiya; Hiroaki Sato; Tamaki Sato; Linda Wykes; Mengyin Hong; Roupen Hatzakorzian; Arnold S Kristof; Thomas Schricker
Journal:  Crit Care       Date:  2021-12-17       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.